The FERO–Ricky Rubio Foundation Lung Cancer Grant 2027 supports translational research that could improve how lung cancer is diagnosed or treated. FERO Cancer and The Ricky Rubio Foundation are seeking projects with a clear route to clinical use and the potential to improve quality of life for people with lung cancer.
Researchers of any nationality may apply if they meet the award’s requirements for research leadership and institutional affiliation in Spain. The first stage requires a short proposal and the principal investigator’s CV.
Eligibility Criteria
- Hold a PhD, a cancer-related clinical specialty obtained through Spain’s MIR programme, or both.
- Have a track record in translational lung cancer research with clear clinical relevance.
- Lead a research group at an eligible centre in Spain by the time of the award.
- Be affiliated with an eligible public or private nonprofit research institution in Spain by the award date. Applicants awaiting an appointment must submit a signed host commitment letter.
- Have secured competitive funding as principal investigator for at least one research, development, or innovation project in the past three years.
- Submit one original proposal. The same activities cannot already be funded, and the same proposal cannot be submitted to another FERO call in this round.`
Funding Details
- Award: €100,000 over two years.
- Number of awards: One planned.
- Indirect costs: Up to 5% of eligible direct costs, excluding external services and subcontracting from the calculation.
Deadline
- Short proposal: November 13, 2026, at 3:00 p.m. CET. Submit a proposal in English of up to three pages.
- Shortlist notification: December 18, 2026.
- Invited full proposal: January 29, 2027, at 3:00 p.m. CET.
- Expected decision: Late March 2027.